Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found.

Armed with Phase III win, Incyte eyes label expansion for Monjuvi

Incyte’s Monjuvi is approved by the US FDA as a second-line treatment of relapsed and refractory diffuse large B cell lymphoma (DLBCL) in combination with

August 16, 2024

MSOS stock analysis – MSOS stock continues higher with End-Of-Day Selling

September 9, 2023

Suven to acquire controlling stake in Sapala Organics

The acquisition is aimed at expanding Suven’s CDMO business in oligonucleotide technology. Credit: Ekaterina 1525 / Shutterstock. India-based Suven Pharmaceuticals has announced a definitive agreement

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.